Try our mobile app

Published: 2021-10-12 08:37:04 ET
<<<  go to IBM company page
0000051143 false Capital stock, par value $.20 per share IBM CHX 0000051143 2021-10-12 2021-10-12 0000051143 us-gaap:CommonStockMember exch:XCHI 2021-10-12 2021-10-12 0000051143 us-gaap:CommonStockMember exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Notes2.625PercentDue2022Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Notes1.25PercentDue2023Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Notes0.375PercentDue2023Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Notes1.125PercentDue2024Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Notes2.875PercentDue2025Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Notes0.950PercentDue2025Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Notes0.875PercentDue2025Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Notes0.300PercentDue2026Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Notes1.250PercentDue2027Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Notes0.300PercentDue2028Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Notes1.750PercentDue2028Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Notes1.500PercentDue2029Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Notes1.750PercentDue2031Member exch:XNYS 2021-10-12 2021-10-12 0000051143 exch:XNYS ibm:Notes0.650PercentDue2032Member 2021-10-12 2021-10-12 0000051143 exch:XNYS ibm:Notes1.200PercentDie2040Member 2021-10-12 2021-10-12 0000051143 ibm:Debentures7.00PercentDue2025Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Debentures6.22PercentDue2027Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Debentures6.50PercentDue2028Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Debentures7.00PercentDue2045Member exch:XNYS 2021-10-12 2021-10-12 0000051143 ibm:Debentures7.125PercentDue2096Member exch:XNYS 2021-10-12 2021-10-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

Title of each class
Trading symbol

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549  

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d)

OF THE SECURITIES EXCHANGE ACT OF 1934 

 

Date of Report (Date of earliest event reported): October 12, 2021

 

 

 

INTERNATIONAL BUSINESS MACHINES CORPORATION

(Exact name of registrant as specified in its charter)

 

New York   1-2360   13-0871985
(State or other jurisdiction
of incorporation)
  (Commission
File No.)
  (IRS employee
Indemnification No.)

 

One New Orchard Road

   
Armonk, New York   10504
(Address of principal executive offices)   (Zip Code)

 

914-499-1900

(Registrar’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of each class   Trading
Symbol(s)
  Name of each exchange
on which registered
Capital stock, par value $.20 per share   IBM   New York Stock Exchange
        NYSE Chicago
2.625% Notes due 2022   IBM 22A   New York Stock Exchange
1.250% Notes due 2023   IBM 23A   New York Stock Exchange
0.375% Notes due 2023   IBM 23B   New York Stock Exchange
1.125% Notes due 2024   IBM 24A   New York Stock Exchange
2.875% Notes due 2025   IBM 25A   New York Stock Exchange
0.950% Notes due 2025   IBM 25B   New York Stock Exchange
0.875% Notes due 2025   IBM 25C   New York Stock Exchange
0.300% Notes due 2026   IBM 26B   New York Stock Exchange
1.250% Notes due 2027   IBM 27B   New York Stock Exchange
0.300% Notes due 2028   IBM 28B   New York Stock Exchange
1.750% Notes due 2028   IBM 28A   New York Stock Exchange
1.500% Notes due 2029   IBM 29   New York Stock Exchange
1.750% Notes due 2031   IBM 31   New York Stock Exchange
0.650% Notes due 2032   IBM 32A   New York Stock Exchange
1.200% Notes due 2040   IBM 40   New York Stock Exchange
7.00% Debentures due 2025   IBM 25   New York Stock Exchange
6.22% Debentures due 2027   IBM 27   New York Stock Exchange
6.50% Debentures due 2028   IBM 28   New York Stock Exchange
7.00% Debentures due 2045   IBM 45   New York Stock Exchange
7.125% Debentures due 2096   IBM 96   New York Stock Exchange

 

Indicate by check mark whether the registrar is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230 405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 8.01Other Events.

 

On October 12, 2021, International Business Machines Corporation (“IBM”) announced the timing and details regarding IBM’s distribution of 80.1% of the outstanding shares of common stock, par value $0.01 per share, of Kyndryl Holdings, Inc. (“Kyndryl”), a wholly owned subsidiary of IBM (the “Kyndryl Common Stock”), to IBM’s holders of common stock (“IBM stockholders”) as a pro rata dividend in a spin-off. Following the distribution, IBM will retain 19.9% of the outstanding Kyndryl Common Stock. IBM intends to dispose of any retained Kyndryl Common Stock within 12 months after the distribution. The IBM board of directors has declared a pro rata dividend of Kyndryl Common Stock to be made effective at 5:00 p.m., New York City time, on Wednesday, November 3, 2021, to IBM’s stockholders of record as of the close of business, on Monday, October 25, 2021 (the “Record Date”). Each IBM stockholder of record on the Record Date will receive a distribution of one share of Kyndryl Common Stock for every five shares of common stock, par value $0.20 per share, of IBM, that it holds on the Record Date. IBM stockholders will receive cash in lieu of fractional shares of Kyndryl Common Stock. The distribution is subject to the satisfaction or waiver of certain conditions. A copy of the press release is included herewith as Exhibit 99.1, and is incorporated by reference herein.

 

Forward-Looking Statements

 

Statements in this report regarding the spin-off and separation constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “believes,” “plans,” “anticipates,” “expects,” “intends” or “estimates” or similar expressions) should also be considered to be forward-looking statements. Forward-looking statements are based on the IBM’s current assumptions regarding future business and financial performance. These statements, by their nature, address matters that are uncertain to different degrees. These statements involve a number of factors that could cause actual results to differ materially. Additional information concerning these factors is contained in IBM’s most recent Form 10-K, Form 10-Q and other filings with the Securities and Exchange Commission (the “SEC”), as well as those risk factors described in Kyndryl’s Registration Statement on Form 10 (the “Registration Statement”). Copies of IBM filings are available from the SEC, from the IBM website or from IBM Investor Relations. Copies of Kyndryl’s Registration Statement is available from the SEC. We disclaim any obligation to update any forward-looking statements as a result of developments occurring after the date of this report.

 

Item 9.01Financial Statements and Exhibits.

 

(d)    Exhibits.

 

Exhibit No     Description  
99.1   Press Release dated October 12, 2021.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  INTERNATIONAL BUSINESS MACHINES CORPORATION
   
  By: /s/Frank Sedlarcik
    Name: Frank Sedlarcik
    Title: Vice President, Assistant General Counsel and Secretary

 

Date: October 12, 2021